Fraxiparine

Fraxiparine is a low-molecular-weight heparin used for anticoagulation. It helps prevent blood clots in various medical conditions, including haemodialysis and surgical procedures.

Fraxiparine is primarily used for anticoagulation, which means it helps prevent blood clots from forming. It is commonly used during haemodialysis to keep blood flowing smoothly through the dialysis machine. Additionally, it may be used to prevent blood clots in surgical patients or those with certain medical conditions that increase the risk of clotting. Fraxiparine can be administered intravenously or subcutaneously, depending on the specific needs of the patient.

Fraxiparine works by inhibiting certain clotting factors in the blood, which helps to prevent the formation of blood clots. Common effects may include bruising or bleeding at the injection site. Some individuals may also experience mild pain or irritation at the site of administration. These effects are generally mild and temporary.

Fraxiparine should be used with caution in individuals with a history of bleeding disorders or those who are at high risk for bleeding. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should also be monitored regularly for signs of bleeding or other adverse effects.

Fraxiparine may interact with other medications that affect blood clotting, such as warfarin or aspirin. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, certain medical conditions, such as kidney or liver disease, may affect how Fraxiparine works in the body.